Cycle for Survival at Equinox Bethesda
Fundraising Event Driving Research into New Rare Cancer Treatments Marks 2nd Year in Washington DC/Bethesda
WHAT: Join the battle against rare cancers by registering to ride with your friends and family in Cycle for Survival, the nationwide indoor team cycling event that has raised more than $17 million in six years and is driving research led by Memorial Sloan-Kettering Cancer Center into rare cancers, such as pancreatic cancer, sarcoma and ovarian cancer, benefitting patients all over the world. Teams register to ride for a four hour shift, with a maximum of 8 riders per bike. Teams may register multiple bikes. The event also features complimentary yoga classes, massage therapy and children's activities.
The nation's oldest and largest, private cancer research and treatment institution, Memorial Sloan-Kettering treats more than 400 different types of cancer, and is leading advances in cancer research and treatments, including into the rarest forms of the disease, benefitting patients worldwide.
WHEN: Registration opened in September and is held throughout the fall 2012
Event date: Sunday, February 10, 2013 (Session Times 10am-2pm and 3 pm-7pm)
LOCATION: Equinox Bethesda
4905 Elm Street Bethesda, MD 20814
Rachel Edery, Edelman
(office) 212-729-2182 (mobile) 347-232-4130
Cycle for Survival is the national, indoor team cycling event that funds research led by Memorial Sloan-Kettering Cancer Center (MSK) into rare cancers. The event was started in 2007 by rare cancer patient Jennifer Goodman Linn, and together with Founding Partner, Equinox, Cycle for Survival has become one of the world's fastest growing athletic fundraising events. In the past six years, Cycle for Survival has raised more than $17 million. Within six months of the events, every dollar raised is allocated to research projects led by MSK. This means patients quickly see the benefits of donations in the form of new clinical trials and investigational treatment options. Half of all people with cancer suffer from a rare form of the disease like pancreatic or ovarian cancer, but research is often underfunded, leaving patients with few treatment options. Through 2012, Cycle has funded more than 50 clinical trials and research studies into rare cancers. For more information, go to www.cycleforsurvival.org.